Codelivery of IL-7 Augments Multigenic HCV DNA Vaccine-induced Antibody as well as Broad T Cell Responses in Cynomolgus Monkeys
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: A crucial limitation of DNA vaccines is its weak immunogenicity, especially in terms of eliciting antibody responses in non-human primates or humans; therefore, it is essential to enhance immune responses to vaccination for the development of successful DNA vaccines for humans. Methods: Here, we approached this issue by evaluating interleukin-7 (IL-7) as a genetic adjuvant in cynomolgus monkeys immunized with multigenic HCV DNA vaccine. Results: Codelivery of human IL-7 (hIL-7)-encoding DNA appeared to increase DNA vaccine-induced antibody responses specific for HCV E2 protein, which plays a critical role in protecting from HCV infection. HCV-specific T cell responses were also significantly enhanced by codelivery of hIL-7 DNA. Interestingly, the augmentation of T cell responses by codelivery of hIL-7 DNA was shown to be due to the enhancement of both the breadth and magnitude of immune responses against dominant and subdominant epitopes. Conclusion: Taken together, these findings suggest that the hIL-7-expressing plasmid serves as a promising vaccine adjuvant capable of eliciting enhanced vaccine-induced antibody and broad T cell responses.
Abstract
Background: A crucial limitation of DNA vaccines is its weak immunogenicity, especially in terms of eliciting antibody responses in non-human primates or humans; therefore, it is essential to enhance immune responses to vaccination for the development of successful DNA vaccines for humans. Methods: Here, we approached this issue by evaluating interleukin-7 (IL-7) as a genetic adjuvant in cynomolgus monkeys immunized with multigenic HCV DNA vaccine. Results: Codelivery of human IL-7 (hIL-7)-encoding DNA appeared to increase DNA vaccine-induced antibody responses specific for HCV E2 protein, which plays a critical role in protecting from HCV infection. HCV-specific T cell responses were also significantly enhanced by codelivery of hIL-7 DNA. Interestingly, the augmentation of T cell responses by codelivery of hIL-7 DNA was shown to be due to the enhancement of both the breadth and magnitude of immune responses against dominant and subdominant epitopes. Conclusion: Taken together, these findings suggest that the hIL-7-expressing plasmid serves as a promising vaccine adjuvant capable of eliciting enhanced vaccine-induced antibody and broad T cell responses.
참고문헌 (33)
- Kiyosawa K, "Transition of antibody to hepatitis C virus from chronic hepatitis to hepatocellular carcinoma", Jpn J Cancer Res, 81, pp.1089~1091 (1990)
- Alter MJ, "The prevalence of hepatitis C virus infection in the United States, 1988 through 1994", N Engl J Med, 341, pp.556~562 (1999)
- Nascimbeni M, "Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees", J Virol, 77, pp.4781~4793 (2003)
- Lanford RE, "Cross-genotype immunity to hepatitis C virus", J Virol, 78, pp.1575~1581 (2004)
- Folgori A, "A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees", Nat Med, 12, pp.190~197 (2006)
- Youn JW, "Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee", Hepatology, 42, pp.1429~1436 (2005)
- Forns X, "Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV", Hepatology, 32, pp.618~625 (2000)
- Pertmer TM, "Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery", J Virol, 70, pp.6119~6125 (1996)
- Fynan EF, "DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations", Proc Natl Acad Sci USA, 90, pp.11478~11482 (1993)
- Choi SY, "Enhancement of DNA vaccine-induced immune responses by influenza virus NP gene", Immune Netw, 9, pp.178~ (2009)
- Barouch DH, "The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses", Immunol Rev, 202, pp.266~274 (2004)
- Appasamy PM, "Biological and clinical implications of interleukin-7 and lymphopoiesis", Cytokines Cell Mol Ther, 5, pp.25~39 (1999)
- Faltynek CR, "Administration of human recombinant IL-7 to normal and irradiated mice increases the numbers of lymphocytes and some immature cells of the myeloid lineage", J Immunol, 149, pp.1276~1282 (1992)
- Komschlies KL, "Administration of recombinant human IL-7 to mice alters the composition of B-lineage cells and T cell subsets, enhances T cell function, and induces regression of established metastases", J Immunol, 152, pp.5776~5784 (1994)
- Morrissey PJ, "Recombinant interleukin 7, pre-B cell growth factor, has costimulatory activity on purified mature T cells", J Exp Med, 169, pp.707~716 (1989)
- Alderson MR, "Interleukin 7 enhances cytolytic T lymphocyte generation and induces lymphokine-activated killer cells from human peripheral blood", J Exp Med, 172, pp.577~587 (1990)
- Schluns KS, "Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo", Nat Immunol, 1, pp.426~432 (2000)
- Tan JT, "IL-7 is critical for homeostatic proliferation and survival of naive T cells", Proc Natl Acad Sci USA, 98, pp.8732~8737 (2001)
- Boise LH, "Growth factors can enhance lymphocyte survival without committing the cell to undergo cell division", Proc Natl Acad Sci USA, 92, pp.5491~5495 (1995)
- Maeurer MJ, "Interleukin-7 or interleukin-15 enhances survival of Mycobacterium tuberculosis-infected mice", Infect Immun, 68, pp.2962~2970 (2000)
- Sin JI, "Interleukin 7 can enhance antigen-specific cytotoxic-T-lymphocyte and", or Th2- type immune responses in vivo, 2000, pp.7, 751~758
- Calarota SA, "IL-15 as memory T-cell adjuvant for topical HIV-1 DermaVir vaccine", Vaccine, 26, pp.5188~5195 (2008)
- Melchionda F, "Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool", J Clin Invest, 115, pp.1177~1187 (2005)
- Geiselhart LA, "IL-7 administration alters the CD4:CD8 ratio, increases T cell numbers, and increases T cell function in the absence of activation", J Immunol, 166, pp.3019~3027 (2001)
- Lee KJ, "Hepatitis C virus E2 protein purified from mammalian cells is frequently recognized by E2-specific antibodies in patient sera", J Biol Chem, 272, pp.30040~30046 (1997)
- Sheehan JJ, "Fibrin-modifying serine proteases thrombin, tPA, and plasmin in ischemic stroke: a review", Glia, 50, pp.340~350 (2005)
- Youn JW, "Optimal induction of T-cell responses against hepatitis C virus E2 by antigen engineering in DNA immunization", J Virol, 77, pp.11596~11602 (2003)
- Park SH, "Efficient induction of T helper 1 CD4+ T-cell responses to hepatitis C virus core and E2 by a DNA prime-adenovirus boost", Vaccine, 21, pp.4555~4564 (2003)
- Park SH, "Codelivery of PEG-IFN-alpha inhibits HCV DNA vaccine-induced T cell responses but not humoral responses in African green monkeys", Vaccine, 26, pp.3978~3983 (2008)
- Ma A, "Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis", Annu Rev Immunol, 24, pp.657~679 (2006)
- Sinha ML, "Interleukin 7 worsens graft-versus-host disease", Blood, 100, pp.2642~2649 (2002)
- Milne CD, "IL-7: a key regulator of B lymphopoiesis", Semin Immunol, 18, pp.20~30 (2006)
- Morrissey PJ, "Administration of IL-7 to normal mice stimulates B-lymphopoiesis and peripheral lymphadenopathy", J Immunol, 147, pp.561~568 (1991)
